Rhythm Pharmaceuticals, Inc. RYTM Debt-to-assets
Debt-to-assets at other companies
Other financials
Where this comes from
Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s debt-to-assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s debt-to-assets?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported debt-to-assets of 0.3× in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s debt-to-assets changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s debt-to-assets decreased by 13.6% year-over-year, from 0.3× to 0.3×.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s debt-to-assets?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s debt-to-assets has grown at a 50.7% compound annual growth rate (CAGR), from 0× to 0.2×.
- What does debt-to-assets mean?
- Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.